Abstract:Intracranial atherosclerotic stenosis (ICAS) is one of the most common causes of stroke worldwide, in particular in Chinese, Black and Hispanic populations compared with Caucasians [ 1 Wong L.K. Global burden of intracranial atherosclerosis. Int. J. Stroke. 2006; 1: 158-159 Crossref PubMed Scopus (445) Google Scholar , 2 Gorelick P.B. Wong K.S. Bae H.J. Pandey D.K. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008; 39: 2396-2399 Crossref PubMed Scopus (518) Google Scholar ]. In addition to the medical therapy, angioplasty and stenting are alterative surgical approaches. However, recent AHA/ASA guideline on stroke prevention recommended not to adopt stenting with the Wingspan stent system as an initial treatment for patients with stroke or transient ischemic attack attributable to severe (70%–99%) ICAS (class III, level C) [ [3] Kernan W.N. Ovbiagele B. Black H.R. Bravata D.M. Chimowitz M.I. Ezekowitz M.D. et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45: 2160-2236 Crossref PubMed Scopus (3181) Google Scholar ]. This recommendation was formulated based on the only randomized clinical trial — Stenting and Aggressive Medical Management for Prevention Recurrent Stroke and Intracranial Stenosis (SAMMPRIS) trial, which demonstrated that stenting had higher risk for 30-day and long-term stroke and death than aggressive medical therapy in patients with severe ICAS [ 4 Chimowitz M.I. Lynn M.J. Derdeyn C.P. Turan T.N. Fiorella D. Lane B.F. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 2011; 365: 993-1003 Crossref PubMed Scopus (1397) Google Scholar , 5 Derdeyn C.P. Chimowitz M.I. Lynn M.J. Fiorella D. Turan T.N. Janis L.S. et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014; 383: 333-341 Abstract Full Text Full Text PDF PubMed Scopus (576) Google Scholar ]. However, this trial was performed in Caucasians [ [4] Chimowitz M.I. Lynn M.J. Derdeyn C.P. Turan T.N. Fiorella D. Lane B.F. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 2011; 365: 993-1003 Crossref PubMed Scopus (1397) Google Scholar ]. Asians have more ICAS, and more diffuse lesions, whether the SAMMPRIS result validate in Chinese patients, also needs further investigation.

Femoral-Long Sheath-Reshape-Anchoring-Stenting (FLRAS) Technique in Venous Sinus Stenting for Idiopathic Intracranial Hypertension.

Current Status of the Application of Intracranial Venous Sinus Stenting

Safety and Efficacy of Intravascular Ultrasound As an Adjunct to Stenting for Cerebral Venous Sinus Stenosis-Induced Idiopathic Intracranial Hypertension: a Pilot Study

Study on Unilateral Venous Sinus Stent Implantation in the Treatment of Idiopathic Intracranial Hypertension

Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis with Low Profile Visualized Intraluminal Support Stent.

Long-term safety and efficacy of stenting on correcting internal jugular vein and cerebral venous sinus stenosis

Dural venous sinus stenting in patients with idiopathic intracranial hypertension: report of outcomes from a single-center prospective database and literature review

Neuroform EZ Stenting for Symptomatic Intracranial Artery Stenosis: 30 Days Outcomes in a High-Volume Stroke Center

Venous sinus stenting for idiopathic intracranial hypertension: An updated Meta-analysis

Balloon-Assisted Thrombectomy and Intrasinus Urokinase Thrombolysis for Severe Cerebral Venous Sinus Thrombosis

Analysis of cerebral venous sinus stenosis by flat panel angiographic CT (FP-CT) to guide treatment for idiopathic intracranial hypertension

225 intracranial aneurysms treated with the Low-profile Visualized Intraluminal Support (LVIS) stent: a single-center retrospective study.

Weighing in on the Off-Label Use: Initial Experience of Neuroform EZ Stenting for Intracranial Arterial Stenosis in 45 Patients.

Redefining treatment expectations: exploring mid- and long-term outcomes of venous sinus stenting in idiopathic intracranial hypertension

Abstract T P106: Stenting for Extracranial Vertebral Artery Stenosis: Results from China Interventional Stroke Registry

Long-Term Risk Factors for Intracranial In-Stent Restenosis from a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China

416 Redefining Treatment Expectations: Exploring Long-Term Outcomes of Venous Sinus Stenting in Idiopathic Intracranial Hypertension

Venous sinus stenting for the treatment of acute blindness in a patient with idiopathic intracranial hypertension

Safety and Efficacy Analyses of Angioplasty and Stenting for Severe Intracranial Arterial Stenosis: A Single-Center Retrospective Study in China

The Safety and Efficacy of Low Profile Visualized Intraluminal Support (LVIS) Stents in Assisting Coil Embolization of Intracranial Saccular Aneurysms: a Single Center Experience

The Safety and Long-Term Outcomes of Angioplasty and Stenting in Symptomatic Intracranial Atherosclerotic Stenosis